>Title;Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care.
>Date;06/07/2017
>Journal;PLoS One
>Conflict;NA
